Dissection of the immunomodulatory effects of ES-62 on inflammatory autoimmune disease

McGrath, M.A. and Kean, D.E. and McInnes, I.B. and Harnett, W. and Harnett, M.M. (2008) Dissection of the immunomodulatory effects of ES-62 on inflammatory autoimmune disease. Immunology, 125 (s1). pp. 122-123. ISSN 0019-2805 (https://doi.org/10.1111/j.1365-2567.2008.02974.x)

Abstract

The phosphorylcholine-containing glycoprotein ES-62, secreted from filarial nematodes, may have therapeutic potential in autoimmune inflammatory disease as it has been shown to possess the ability to selectively inhibit aberrant pro-inflammatory cytokine production without leaving the host immunocompromised.

ORCID iDs

Harnett, W. ORCID: https://orcid.org/0000-0001-9545-9401

• Share and Export
  

  RDF+XMLBibTeXRIOXX2 XMLRDF+N-TriplesJSONDublin CoreAtomSimple MetadataReferMETSHTML CitationASCII CitationOpenURL ContextObjectEndNoteOpenURL ContextObject in SpanMODSMPEG-21 DIDLEP3 XMLData Cite XMLRIS (EndNote Online, Zotero, Ref manager, etc)RDF+N3Multiline CSV
• Citations and altmetrics
• Item metadata

  Item type:	Article
  ID code:	19305
  Dates:	Date Event December 2008 Published
  Keywords:	immunomodulatory, inflammatory autoimmune disease, ES-62, Pharmacy and materia medica, Immunology, Immunology, Immunology and Allergy
  Subjects:	Medicine > Pharmacy and materia medica Science > Microbiology > Immunology
  Department:	Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences > Centre for Biophotonics
  Depositing user:	Strathprints Administrator
  Date deposited:	18 May 2010 14:29
  Last modified:	08 Dec 2023 19:04
  URI:	https://strathprints.strath.ac.uk/id/eprint/19305